Adc Therapeutics Sa (ADCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
07-2008 | 04-2008 | 01-2008 | 10-2007 | 07-2007 | |
Cash Flows From Operating Activities | |||||
Net Income | 1,000 | -12,400 | -28,400 | 123,500 | 120,500 |
Depreciation Amortization | 63,200 | 41,700 | 20,600 | 69,500 | 52,500 |
Income taxes - deferred | -1,300 | -900 | -2,500 | -6,200 | 700 |
Accounts receivable | 3,000 | -5,000 | 26,000 | -15,000 | -12,200 |
Accounts payable and accrued liabilities | -24,200 | -17,100 | -15,100 | 1,000 | 2,100 |
Other Working Capital | -43,700 | -50,500 | -39,800 | -29,700 | -11,600 |
Other Operating Activity | 112,500 | 98,600 | 44,300 | -1,300 | -56,300 |
Operating Cash Flow | $110,500 | $54,400 | $5,100 | $141,800 | $95,700 |
Cash Flows From Investing Activities | |||||
PPE Investments | -30,500 | -19,800 | -7,300 | -29,200 | -24,100 |
Net Acquisitions | -199,400 | -199,400 | -197,100 | -1,000 | -1,100 |
Purchase Of Investment | -9,900 | -9,900 | -4,700 | -1,010,200 | -891,200 |
Sale Of Investment | 39,700 | 39,700 | 36,700 | 1,263,200 | 816,200 |
Other Investing Activity | -1,200 | 900 | 0 | -900 | 900 |
Investing Cash Flow | $-201,300 | $-188,500 | $-172,400 | $221,900 | $-99,300 |
Cash Flows From Financing Activities | |||||
Debt Issued | 231,100 | 432,000 | 450,000 | N/A | N/A |
Common Stock Issued | 400 | 300 | 300 | 4,800 | 3,600 |
Other Financing Activity | -10,700 | -10,700 | -10,700 | 0 | 0 |
Financing Cash Flow | $220,800 | $421,600 | $439,600 | $4,800 | $3,600 |
Exchange Rate Effect | 6,300 | 5,600 | 100 | 9,500 | 6,700 |
Beginning Cash Position | 520,200 | 520,200 | 520,200 | 142,200 | 142,200 |
End Cash Position | 656,500 | 813,300 | 792,600 | 520,200 | 148,900 |
Net Cash Flow | $136,300 | $293,100 | $272,400 | $378,000 | $6,700 |
Free Cash Flow | |||||
Operating Cash Flow | 110,500 | 54,400 | 5,100 | 141,800 | 95,700 |
Capital Expenditure | -30,700 | -19,900 | -7,400 | -30,400 | -25,100 |
Free Cash Flow | 79,800 | 34,500 | -2,300 | 111,400 | 70,600 |